- Home
- BHM vs ICCM Comparison
BHM vs ICCM Comparison
Compare BHM & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHM
- ICCM
- Stock Information
- Founded
- BHM 2022
- ICCM 2006
- Country
- BHM United States
- ICCM Israel
- Employees
- BHM N/A
- ICCM N/A
- Industry
- BHM Real Estate Investment Trusts
- ICCM
- Sector
- BHM Real Estate
- ICCM
- Exchange
- BHM Nasdaq
- ICCM Nasdaq
- Market Cap
- BHM 58.8M
- ICCM 59.9M
- IPO Year
- BHM N/A
- ICCM N/A
- Fundamental
- Price
- BHM $13.79
- ICCM $0.89
- Analyst Decision
- BHM Strong Buy
- ICCM Strong Buy
- Analyst Count
- BHM 1
- ICCM 1
- Target Price
- BHM $15.00
- ICCM $2.50
- AVG Volume (30 Days)
- BHM 2.1K
- ICCM 2.6M
- Earning Date
- BHM 01-01-0001
- ICCM 08-19-2025
- Dividend Yield
- BHM 3.68%
- ICCM N/A
- EPS Growth
- BHM N/A
- ICCM N/A
- EPS
- BHM N/A
- ICCM N/A
- Revenue
- BHM $67,757,000.00
- ICCM $3,273,000.00
- Revenue This Year
- BHM N/A
- ICCM $75.27
- Revenue Next Year
- BHM N/A
- ICCM $129.39
- P/E Ratio
- BHM N/A
- ICCM N/A
- Revenue Growth
- BHM 26.16
- ICCM 0.34
- 52 Week Low
- BHM $9.30
- ICCM $0.48
- 52 Week High
- BHM $18.99
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- BHM 53.05
- ICCM 34.87
- Support Level
- BHM $13.99
- ICCM $0.96
- Resistance Level
- BHM $14.45
- ICCM $1.07
- Average True Range (ATR)
- BHM 0.35
- ICCM 0.06
- MACD
- BHM -0.11
- ICCM -0.01
- Stochastic Oscillator
- BHM 22.83
- ICCM 5.85
About BHM Bluerock Homes Trust Inc.
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.